Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Sales ratio high or low?
The EV/Sales ratio of 4.70x is 32% below its estimated 5-year average of 6.93x, near the low end of its estimated 5-year range (3.33x–15.35x).
As of 2026-10-06T19:40:26.533Z. 24.79% below its estimated 12-month average of 6.25x.
Calculation as of: 2026-10-06T19:40:26.533Z.
Quote observation: 2026-10-06T19:40:17.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: cc8bc0f3c1d6793fd8eee0ad66748b6583cc3e3afc130d7083cfc2a78972af23
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
4.70x
EV/SALES RATIO AVG TTM
6.25x
EV/SALES RATIO AVG 3Y
8.23x
EV/SALES RATIO AVG 5Y
6.93x
EV/SALES RATIO AVG 10Y
7.53x
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-24.79%
CURRENT VS 3Y AVG
-42.86%
CURRENT VS 5Y AVG
-32.17%
CURRENT VS 10Y AVG
-37.55%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.37x
median of 549 covered companies
CURRENT VS SECTOR MEDIAN
+7.55%
vs the sector median at left
ADMA Biologics, Inc.
Market Cap
$2.34B
EV/Sales Ratio
4.70x
TTM Avg
6.25x
3Y Avg
8.23x
5Y Avg
6.93x
Market Cap
$2.34B
EV/Sales Ratio
63.25x
TTM Avg
32.84x
3Y Avg
20.79x
5Y Avg
19.67x
Market Cap
$2.33B
EV/Sales Ratio
3.88x
TTM Avg
3.28x
3Y Avg
4.01x
5Y Avg
3.61x
Market Cap
$2.30B
EV/Sales Ratio
4.76x
TTM Avg
36.32x
3Y Avg
51.31x
5Y Avg
39.39x
Market Cap
$2.40B
EV/Sales Ratio
0.89x
TTM Avg
0.75x
3Y Avg
0.67x
5Y Avg
0.62x
Market Cap
$2.40B
EV/Sales Ratio
34.89x
TTM Avg
23.51x
3Y Avg
28.15x
5Y Avg
52.69x
Market Cap
$2.28B
EV/Sales Ratio
1.96x
TTM Avg
1.80x
3Y Avg
2.39x
5Y Avg
4.32x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ADMA Biologics, Inc. (ADMA) | $2.34B | 4.70x | 6.25x | 8.23x | 6.93x |
| Nurix Therapeutics, Inc. (NRIX)vs › | $2.34B | 63.25x | 32.84x | 20.79x | 19.67x |
| UFP Technologies, Inc. (UFPT)vs › | $2.33B | 3.88x | 3.28x | 4.01x | 3.61x |
| Disc Medicine, Inc. (IRON)vs › | $2.37B | N/A | N/A | N/A | N/A |
| Liquidia Corporation (LQDA)vs › | $2.30B | 4.76x | 36.32x | 51.31x | 39.39x |
| Clover Health Investments, Corp. (CLOV)vs › | $2.40B | 0.89x | 0.75x | 0.67x | 0.62x |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.40B | 34.89x | 23.51x | 28.15x | 52.69x |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.28B | 1.96x | 1.80x | 2.39x | 4.32x |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.23B | N/A | N/A | N/A | N/A |
| Supernus Pharmaceuticals, Inc. (SUPN)vs › | $2.48B | 2.81x | 3.62x | 3.07x | 3.23x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-10-05 | 4.68x |
| 2026-10-02 | 4.50x |
| 2026-10-01 | 4.60x |
| 2026-09-30 | 4.64x |
| 2026-09-29 | 4.61x |
| 2026-09-28 | 4.68x |
| 2026-09-25 | 4.35x |
| 2026-09-24 | 4.41x |
| 2026-09-23 | 4.49x |
| 2026-09-22 | 4.54x |
| 2026-09-21 | 4.41x |
| 2026-09-18 | 4.23x |
| 2026-09-17 | 4.16x |
| 2026-09-16 | 4.13x |
| 2026-09-15 | 4.00x |
| 2026-09-14 | 4.24x |
| 2026-09-11 | 4.28x |
| 2026-09-10 | 4.35x |
| 2026-09-09 | 4.38x |
| 2026-09-08 | 4.42x |
| 2026-09-04 | 4.46x |
| 2026-09-03 | 4.44x |
| 2026-09-02 | 4.41x |
| 2026-09-01 | 4.33x |
| 2026-08-31 | 4.35x |
| 2026-08-28 | 4.33x |
| 2026-08-27 | 4.39x |
| 2026-08-26 | 4.46x |
| 2026-08-25 | 4.50x |
| 2026-08-24 | 4.43x |
| 2026-08-21 | 4.56x |
| 2026-08-20 | 4.52x |
| 2026-08-19 | 4.65x |
| 2026-08-18 | 4.42x |
| 2026-08-17 | 4.33x |
| 2026-08-14 | 4.39x |
| 2026-08-13 | 4.36x |
| 2026-08-12 | 4.53x |
| 2026-08-11 | 4.58x |
| 2026-08-10 | 4.52x |
| 2026-08-07 | 4.58x |
| 2026-08-06 | 4.66x |
| 2026-08-05 | 4.49x |
| 2026-08-04 | 4.32x |
| 2026-08-03 | 4.24x |
| 2026-07-31 | 4.11x |
| 2026-07-30 | 4.21x |
| 2026-07-29 | 4.23x |
| 2026-07-28 | 4.27x |
| 2026-07-27 | 4.12x |
| 2026-07-24 | 4.02x |
| 2026-07-23 | 4.07x |
| 2026-07-22 | 4.07x |
| 2026-07-21 | 4.17x |
| 2026-07-20 | 4.25x |
| 2026-07-17 | 4.23x |
| 2026-07-16 | 4.28x |
| 2026-07-15 | 4.21x |
| 2026-07-14 | 4.30x |
| 2026-07-13 | 4.35x |
| 2026-07-10 | 4.40x |
| 2026-07-09 | 4.49x |
| 2026-07-08 | 4.44x |
| 2026-07-07 | 4.46x |
| 2026-07-06 | 4.44x |
| 2026-07-02 | 4.34x |
| 2026-07-01 | 4.18x |
| 2026-06-30 | 4.07x |
| 2026-06-29 | 4.07x |
| 2026-06-26 | 4.25x |
| 2026-06-25 | 4.23x |
| 2026-06-24 | 4.22x |
| 2026-06-23 | 4.22x |
| 2026-06-22 | 4.16x |
| 2026-06-18 | 4.04x |
| 2026-06-17 | 4.09x |
| 2026-06-16 | 4.17x |
| 2026-06-15 | 4.13x |
| 2026-06-12 | 3.99x |
| 2026-06-11 | 4.05x |
| 2026-06-10 | 4.12x |
| 2026-06-09 | 3.95x |
| 2026-06-08 | 3.92x |
| 2026-06-05 | 3.88x |
| 2026-06-04 | 3.89x |
| 2026-06-03 | 3.78x |
| 2026-06-02 | 3.71x |
| 2026-06-01 | 3.85x |
| 2026-05-29 | 3.89x |
| 2026-05-28 | 3.86x |
| 2026-05-27 | 3.86x |
| 2026-05-26 | 3.97x |
| 2026-05-22 | 4.01x |
| 2026-05-21 | 4.11x |
| 2026-05-20 | 4.16x |
| 2026-05-19 | 4.19x |
| 2026-05-18 | 4.07x |
| 2026-05-15 | 4.02x |
| 2026-05-14 | 4.13x |
| 2026-05-13 | 4.13x |
| 2026-05-12 | 4.09x |
| 2026-05-11 | 3.84x |
| 2026-05-08 | 3.97x |
| 2026-05-07 | 4.12x |
| 2026-05-06 | 4.80x |
| 2026-05-05 | 4.88x |
| 2026-05-04 | 4.91x |
| 2026-05-01 | 5.01x |
| 2026-04-30 | 4.88x |
| 2026-04-29 | 5.05x |
| 2026-04-28 | 5.19x |
| 2026-04-27 | 5.21x |
| 2026-04-24 | 5.37x |
| 2026-04-23 | 5.28x |
| 2026-04-22 | 5.22x |
| 2026-04-21 | 5.14x |
| 2026-04-20 | 5.19x |
| 2026-04-17 | 5.25x |
| 2026-04-16 | 5.12x |
| 2026-04-15 | 5.08x |
| 2026-04-14 | 5.00x |
| 2026-04-13 | 4.95x |
| 2026-04-10 | 4.62x |
| 2026-04-09 | 4.74x |
| 2026-04-08 | 4.68x |
| 2026-04-07 | 4.41x |
| 2026-04-06 | 4.42x |
| 2026-04-02 | 4.38x |
| 2026-04-01 | 4.34x |
| 2026-03-31 | 4.29x |
| 2026-03-30 | 4.36x |
| 2026-03-27 | 4.41x |
| 2026-03-26 | 3.95x |
| 2026-03-25 | 4.59x |
| 2026-03-24 | 5.40x |
| 2026-03-23 | 6.48x |
| 2026-03-20 | 6.83x |
| 2026-03-19 | 7.16x |
| 2026-03-18 | 7.09x |
| 2026-03-17 | 7.70x |
| 2026-03-16 | 7.56x |
| 2026-03-13 | 7.23x |
| 2026-03-12 | 7.15x |
| 2026-03-11 | 7.47x |
| 2026-03-10 | 7.55x |
| 2026-03-09 | 7.54x |
| 2026-03-06 | 7.34x |
| 2026-03-05 | 7.49x |
| 2026-03-04 | 7.89x |
| 2026-03-03 | 7.81x |
| 2026-03-02 | 7.91x |
| 2026-02-27 | 7.43x |
| 2026-02-26 | 7.24x |
| 2026-02-25 | 7.90x |
| 2026-02-24 | 7.82x |
| 2026-02-23 | 8.20x |
| 2026-02-20 | 8.11x |
| 2026-02-19 | 8.22x |
| 2026-02-18 | 8.05x |
| 2026-02-17 | 8.03x |
| 2026-02-13 | 8.10x |
| 2026-02-12 | 7.85x |
| 2026-02-11 | 8.20x |
| 2026-02-10 | 8.20x |
| 2026-02-09 | 8.24x |
| 2026-02-06 | 8.27x |
| 2026-02-05 | 8.03x |
| 2026-02-04 | 8.30x |
| 2026-02-03 | 8.82x |
| 2026-02-02 | 8.81x |
| 2026-01-30 | 8.71x |
| 2026-01-29 | 8.56x |
| 2026-01-28 | 8.22x |
| 2026-01-27 | 8.35x |
| 2026-01-26 | 8.54x |
| 2026-01-23 | 8.42x |
| 2026-01-22 | 8.76x |
| 2026-01-21 | 8.74x |
| 2026-01-20 | 8.85x |
| 2026-01-16 | 8.71x |
| 2026-01-15 | 8.81x |
| 2026-01-14 | 9.20x |
| 2026-01-13 | 8.91x |
| 2026-01-12 | 9.02x |
| 2026-01-09 | 9.03x |
| 2026-01-08 | 9.09x |
| 2026-01-07 | 9.47x |
| 2026-01-06 | 9.23x |
| 2026-01-05 | 9.07x |
| 2026-01-02 | 9.00x |
| 2025-12-31 | 9.18x |
| 2025-12-30 | 9.24x |
| 2025-12-29 | 9.61x |
| 2025-12-26 | 9.70x |
| 2025-12-24 | 9.83x |
| 2025-12-23 | 9.80x |
| 2025-12-22 | 10.00x |
| 2025-12-19 | 9.85x |
| 2025-12-18 | 9.46x |
| 2025-12-17 | 9.47x |
| 2025-12-16 | 9.64x |
| 2025-12-15 | 9.93x |
| 2025-12-12 | 9.95x |
| 2025-12-11 | 10.25x |
| 2025-12-10 | 10.05x |
| 2025-12-09 | 9.96x |
| 2025-12-08 | 9.75x |
| 2025-12-05 | 9.99x |
| 2025-12-04 | 10.12x |
| 2025-12-03 | 9.92x |
| 2025-12-02 | 9.68x |
| 2025-12-01 | 9.75x |
| 2025-11-28 | 9.65x |
| 2025-11-26 | 9.63x |
| 2025-11-25 | 9.66x |
| 2025-11-24 | 9.22x |
| 2025-11-21 | 8.65x |
| 2025-11-20 | 8.24x |
| 2025-11-19 | 8.03x |
| 2025-11-18 | 7.90x |
| 2025-11-17 | 7.77x |
| 2025-11-14 | 7.84x |
| 2025-11-13 | 7.91x |
| 2025-11-12 | 8.29x |
| 2025-11-11 | 8.07x |
| 2025-11-10 | 7.41x |
| 2025-11-07 | 7.32x |
| 2025-11-06 | 7.07x |
| 2025-11-05 | 8.04x |
| 2025-11-04 | 7.66x |
| 2025-11-03 | 8.04x |
| 2025-10-31 | 8.10x |
| 2025-10-30 | 7.99x |
| 2025-10-29 | 8.13x |
| 2025-10-28 | 8.15x |
| 2025-10-27 | 8.17x |
| 2025-10-24 | 7.95x |
| 2025-10-23 | 7.98x |
| 2025-10-22 | 7.93x |
| 2025-10-21 | 7.70x |
| 2025-10-20 | 7.69x |
| 2025-10-17 | 7.52x |
| 2025-10-16 | 7.62x |
| 2025-10-15 | 7.90x |
| 2025-10-14 | 7.82x |
| 2025-10-13 | 7.61x |
| 2025-10-10 | 7.61x |
| 2025-10-09 | 7.71x |
| 2025-10-08 | 7.65x |
| 2025-10-07 | 7.32x |
| 2025-10-06 | 7.36x |
| 2025-10-03 | 7.67x |
| 2025-10-02 | 7.60x |
| 2025-10-01 | 7.88x |
| 2025-09-30 | 7.67x |
| 2025-09-29 | 7.69x |
| 2025-09-26 | 8.17x |
| 2025-09-25 | 8.02x |
| 2025-09-24 | 8.20x |
| 2025-09-23 | 8.36x |
Showing the most recent 260 of 3,260 data points. The chart above shows the full history.
